Cullinan Associates’s Dynatrace DT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.02M Sell
54,500
-54,500
-50% -$2.08M 0.16% 92
2025
Q4
$4.72M Hold
109,000
0.32% 66
2025
Q3
$5.28M Hold
109,000
0.34% 62
2025
Q2
$6.02M Hold
109,000
0.4% 55
2025
Q1
$5.14M Hold
109,000
0.36% 58
2024
Q4
$5.92M Sell
109,000
-9,036
-8% -$493K 0.38% 58
2024
Q3
$6.4M Hold
118,036
0.36% 60
2024
Q2
$5.28M Hold
118,036
0.3% 69
2024
Q1
$5.48M Hold
118,036
0.31% 69
2023
Q4
$6.46M Hold
118,036
0.36% 61
2023
Q3
$5.52M Hold
118,036
0.32% 71
2023
Q2
$6.08M Buy
+118,036
New +$5.53M 0.33% 74

Other funds holding DT

Cullinan Associates's DT Position: Q1 2026 in Review

Cullinan Associates reduced its Dynatrace (DT) stake by 50% in Q1 2026, selling an estimated $2.08M and leaving 54,500 shares worth $2.02M. The position accounts for 0.16% of the portfolio, ranked #92.

Cullinan Associates first reported a position in DT in Q2 2023 and has held it in 12 quarters since. The position peaked at $6.46M in Q4 2023. 576 funds tracked by Wall St. Rank hold DT as of Q1 2026.

  • Cullinan Associates held 54,500 shares of Dynatrace worth $2.02M as of Q1 2026.
  • Cullinan Associates sold 54,500 Dynatrace shares in Q1 2026, an estimated $2.08M.
  • Dynatrace made up 0.16% of Cullinan Associates's portfolio in Q1 2026, its #92 holding.
  • Cullinan Associates first reported a position in Dynatrace in Q2 2023 and has held it in 12 quarters since.
  • Cullinan Associates's Dynatrace position peaked at $6.46M in Q4 2023.
  • 576 funds tracked by Wall St. Rank held Dynatrace as of Q1 2026.

Based on Cullinan Associates's 13F filing for Q1 2026, filed 1 May 2026.